www.theglobeandmail.com

www.theglobeandmail.com
Share

www.theglobeandmail.com

 •  November 19

Open this photo in gallery: It may be a cross between the Eurovision Song Contest, a papal conclave and a social club raffle but a ballot among EU ministers on Monday could hurt Europe's pharmaceutical industry and the health of millions. It will fix the new home of the European Medicines Agency, which must leave London by 2019 when Britain leaves...

www.theglobeandmail.com

 •  February 14

Doctors and patients should avoid pharmaceuticals that have been on the market for less than three years, according to a Canadian researcher who concluded it regularly takes that long to discover a new drug is unsafe. In a study published on Tuesday in the journal Open Medicine, Joel Lexchin found that 22 of 528 new drugs Health Canada approved...

www.theglobeandmail.com

 •  February 14

The recently announced free-trade deal with Europe will likely cost Canadians hundreds of millions of dollars more for prescription drugs, says a new analysis. The report, by two York University professors, says concessions by the federal government to cement the deal will delay the arrival cheap generic drugs by about a year, on average. And the...

www.theglobeandmail.com

 •  February 14

Canada’s lagging intellectual property protections for pharmaceutical innovators are a key issue to be settled in the Comprehensive Economic and Trade Agreement negotiations with the European Union. They may also play a role in upcoming negotiations for the multi-country Trans-Pacific Partnership. Two new essays on the cost and benefits of stronger...